Log In
Print this Print this


Also known as: Friulimicin B

  Manage Alerts
Collapse Summary General Information
Company MerLion Pharmaceuticals Pte. Ltd.
DescriptionLipopeptide antibiotic
Molecular Target Not applicable
Mechanism of ActionCell membrane integrity disruption
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBacterial infection
Indication DetailsTreat serious hospital infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today